Interference of hypertriglyceridemia on total cholesterol assay with the new CHOL2 Abbott method on Architect analyser
- 6 March 2025
- journal article
- research article
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 63 (7) , e184-e186
Abstract
Article Interference of hypertriglyceridemia on total cholesterol assay with the new CHOL2 Abbott method on Architect analyser was published on March 6, 2025 in the journal Clinical Chemistry and Laboratory Medicine (CCLM) (volume 0, issue 0).Keywords
This publication has 5 references indexed in Scilit:
- A-079 Analytical Assessment of Abbott’s SigmaSTRONG assays on the Alinity c and ARCHITECT c SystemsClinical Chemistry, 2023
- Analytical evaluation and Sigma metrics of 6 next generation chemistry assays on the Abbott Architect systemClinica Chimica Acta, 2023
- Measurements for 8 Common Analytes in Native Sera Identify Inadequate Standardization among 6 Routine Laboratory AssaysClinical Chemistry, 2014
- A Clinician's Guide to the Office Measurement of CholesterolJAMA, 1988
- Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractionsClinica Chimica Acta, 1987